Molecular and Cellular Biochemistry

, Volume 308, Issue 1–2, pp 169–175 | Cite as

Interaction of SIV/SHIV infection and morphine on plasma oxidant/antioxidant balance in macaque

  • Antonio Pérez-Casanova
  • Kazim Husain
  • Richard J. NoelJr.
  • Vanessa Rivera-Amill
  • Anil Kumar
Article

Abstract

A homeostatic balance exists between the cellular generation of oxidant species and endogenous antioxidants under normal physiological conditions. Human Immunodeficiency Virus (HIV) infection is known to affect this balance causing oxidative stress. However, the interaction of HIV infection with a substance abuse on cellular oxidant/antioxidant system is sparse. This study was designed in order to investigate the interactive effect of morphine abuse and Simian Immunodeficiency Virus/ Simian Human Immunodeficiency Virus (SIV/SHIV) infection on plasma oxidant/antioxidant balance in rhesus macaques. Six rhesus macaques adapted to morphine dependence (20 weeks) along with three controls were infected with mixture of SHIVKU-1B, SHIV89.6P, and SIV17E-Fr. Plasma samples from morphine-dependent and control macaques were analyzed for an array of oxidative stress indices after 16 weeks of infection. Morphine-dependence significantly increased plasma malondialdehyde (MDA) and 8-isoprostane levels (8-fold and 2-fold), but these animals showed higher MDA and 8-isoprostane levels after viral infection (18-fold and 4-fold) which was directly correlated with increase in viral load and decline in CD4+ cells. Plasma glutathione (GSH) level depleted (55%) with morphine dependence that was further depleted (25%) by the infection. Activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were increased by 30% and 110%, respectively with morphine dependence, but that was decreased by the infection. Catalase (CAT) activity declined (25%) with morphine dependence that was further declined by infection. Our results clearly suggest that morphine interaction with SIV/SHIV infection causes higher oxidative tissue injury that might have implication in the pathogenesis of AIDS in morphine-dependent macaques.

Keywords

AIDS Antioxidant Oxidative stress Morphine Plasma SIV/SHIV 

Notes

Acknowledgments

This study was supported in part by grants from National Institute of Drug Abuse (DA015013) and National Institute on Alcohol and Alcoholism (AA015045).

References

  1. 1.
    Somani SM, Husain K, Schlorff E (1997) Responses of physical and chemical stresses on antioxidant system. In: Baskin S, Salem H (eds) Oxidants, antioxidants, and free radicals. Taylor and Francis, Washington, DC, 125–141Google Scholar
  2. 2.
    Halliwell B, Gutteridge JM (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219:1–14PubMedGoogle Scholar
  3. 3.
    Stephensen CB, Marquis GS, Douglas SD, Kruzich LA, Wilson CM (2007) Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults. Am J Clin Nutr 85:173–181PubMedGoogle Scholar
  4. 4.
    McLemore JL, Beeley P, Thorton K, Morrisroe K, Blackwell W, DasGupta A (1998) Rapid automated determination of lipid hydroperoxide concentrations and total antioxidant status of serum samples from patients infected with HIV: elevated lipid hydroperoxide concentratios and depleted total antioxidant capacity of serum samples. Am J Clin Pathol 109:268–273PubMedGoogle Scholar
  5. 5.
    Ogunro PS, Ogungbamigbe TO, Ajala MO, Egbewale BE (2005) Total antioxidant status and lipid peroxidation in HIV-1 infected patients in a rural area of south western Nigeria. Afr J Med Sci 34:221–225Google Scholar
  6. 6.
    Buhl R, Jaffe HA, Holroyd KJ (1989) Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 2:1294–1298PubMedCrossRefGoogle Scholar
  7. 7.
    Walmsley SL, Winn LM, Harrison ML (1997) Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: toxicological and pathological implications. AIDS 11:1689–1697PubMedCrossRefGoogle Scholar
  8. 8.
    Jareno EJ, Bosch-Morell F, Fernandez-Delgado R (1998) Serum malondialdehyde in HIV seropositive children. Free Radic Biol Med 24:503–506PubMedCrossRefGoogle Scholar
  9. 9.
    Sandstrom PA, Tebbey PW, Van Cleave S, Buttke TM (1994) Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathione peroxidase deficiency. J Biol Chem 269:798–801PubMedGoogle Scholar
  10. 10.
    Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M Cass W, Turchan JT (2002) Molecular basis for interaction of HIV and drug of abuse. J AIDS 31:S62–S69Google Scholar
  11. 11.
    Centers for Disease Control (1996) Centers for disease control and prevention: update: mortality attributable to HIV infection among persons aged 25–44 years—United States 1994. MMWR 45:121–125Google Scholar
  12. 12.
    Purcell DW, Metsch LR, Latka M et al (2004) Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J AIDS 37:S110–S118Google Scholar
  13. 13.
    Li Y, Merrill JD, Mooney K (2003) Morphine enhances HIV infection of neonatal macrophages. Pediatr Res 54:282–288PubMedCrossRefGoogle Scholar
  14. 14.
    MacFarlane AS, Peng X, Meissler JJ Jr et al (2000) Morphine increases susceptibility to oral Salmonella typhimurium infection. J Infect Dis 181:1350–1358PubMedCrossRefGoogle Scholar
  15. 15.
    Donahoe RM, Vlahov D (1998) Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol 83:77–87PubMedCrossRefGoogle Scholar
  16. 16.
    Prieto-Lastra L, Iglesias-Cadarso A, Reano-Martos MM (2006) Pharmacological stimuli in asthma/urticaria. Allergol Immunopathol (Madr) 34:2224–2227CrossRefGoogle Scholar
  17. 17.
    Atici S, Cinel I, Cinel L (2005) Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model. J Biosci 30:245–252PubMedCrossRefGoogle Scholar
  18. 18.
    Skaper SD, Facci L, Kee WJ (2001) Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurons: a possible role for mast cells. J Neurochem 76:47–55PubMedCrossRefGoogle Scholar
  19. 19.
    Kumar R, Torres C, Yamamura Y, Rodriguez I, Martinez M, Staprans S, Donahoe RM, Kraiselburd E, Stephens EB, Kumar A (2004) Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J Virol 78:11425–11428PubMedCrossRefGoogle Scholar
  20. 20.
    Husain K, Mejia J, Lalla J (2006) Physiological basis for effect of physical conditioning on chronic ethanol-induced hypertension in a rat model. Mol Cell Biochem 289:175–183PubMedCrossRefGoogle Scholar
  21. 21.
    Husain K (2007) Vascular endothelial oxidative stress in alcohol-induced hypertension. Cell Mol Biol 53:69–76Google Scholar
  22. 22.
    Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRefGoogle Scholar
  23. 23.
    Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–3175PubMedGoogle Scholar
  24. 24.
    Johansson LH, Borg LA (1988) A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 174:331–336PubMedCrossRefGoogle Scholar
  25. 25.
    Flohe L, Gunzler W (1984) Assays of glutathione peroxidase. Meth Enzymol 105:114–121PubMedCrossRefGoogle Scholar
  26. 26.
    Read SM, Northcole DH (1981) Minimization of variation in the response to different protein of the Coomassie blue G dye-binding assay for protein. Anal Biochem 116:53–64PubMedCrossRefGoogle Scholar
  27. 27.
    Halliwell B (1987) Oxidants and human disease, some new concepts. FASEB J 1:358–364PubMedGoogle Scholar
  28. 28.
    Pantaleo G, Graziosi C, Fauci AS (1993) The immunopathogenesis of human immunodeficiency virus infection. New Eng J Med 328:327–335PubMedCrossRefGoogle Scholar
  29. 29.
    Werner P, Cohen G (1993) Glutathione disulfide (GSSG) as a marker of oxidative injury to brain mitochondria. Ann NY Acad Sci 679:364–369PubMedCrossRefGoogle Scholar
  30. 30.
    Deleve SM, Kaplowitz N (1990) Importance and regulation of hepatic glutathione. Sami Liv Dis 10:251–256CrossRefGoogle Scholar
  31. 31.
    Younes M, Siegers CP (1981) Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo. Chem Biol Interact 34:257–266PubMedCrossRefGoogle Scholar
  32. 32.
    Aukrust P, Muller F, Svardal AM, Ueland T, Berge RK, Froland SS (2003) Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy-potential immunomodulatory effects of antioxidants. J Infect Dis 188:232–238PubMedCrossRefGoogle Scholar
  33. 33.
    Mikus G, Somogyi AA, Bochner F (1991) Polymorphic metabolism of opioid narcotic drugs: possible clinical implications. Ann Acad Med Singapore 20:9–12PubMedGoogle Scholar
  34. 34.
    Bondy SC (1992) Ethanol toxicity and oxidative stress. Toxicol Lett 63:231–241PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2007

Authors and Affiliations

  • Antonio Pérez-Casanova
    • 1
  • Kazim Husain
    • 2
    • 4
  • Richard J. NoelJr.
    • 1
  • Vanessa Rivera-Amill
    • 1
  • Anil Kumar
    • 1
    • 3
  1. 1.AIDS Research ProgramPonce School of MedicinePonceUSA
  2. 2.Department of PharmacologyPonce School of MedicinePonceUSA
  3. 3.Division of PharmacologySchool of Pharmacy, University of MissouriKansas CityUSA
  4. 4.Department of Physiology, Pharmacology and ToxicologyPonce School of MedicinePonceUSA

Personalised recommendations